Deep Inhalation Breath Hold for reduction of cardiac toxicity in patients with left sided breast cancer undergoing radiotherapy

TROG 14.04 tested the feasibility of Deep Inhalation Breath Hold (DIBH) to reduce heart radiation dose in left sided breast cancer patients in a multicentre setting. Patient reported outcomes such as anxiety associated with holding their breath were also investigated in comparison to right-sided breast cancer patients treated in free breathing (normal breathing). The study confirmed that DIBH has the potential to reduce the radiation dose to the heart for left sidedbreast cancer patients receiving radiotherapy in a variety of settings. There was a slightly higher anxiety scores among DIBH patients suggest the act of breath holding, or knowledge of the purpose of DIBH, may increase patient anxiety. However, this increased anxiety reduced to levels similar to the control group of right sided breast cancer patients throughout the course of their treatment.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Breast Cancer Trials Group (BCTG)

Final Accrual

62

Trial Chairperson

Professor Tomas Kron, Peter MacCallum Cancer Centre, VIC

Trial Contact

HART@trog.com.au

Clinical Trial Registration

Related Post

11 June, 2025

Trial Could Prove a Game-Changer for Treating High-Risk Skin Cancer

LATEST NEWS: 11 JUNE 2025 New findings from a

Grant for PRIME-Lung trial
10 June, 2025

MRFF $1.5m grant for TROG-sponsored trial of new approach in lung cancer

LATEST NEWS: 10 JUNE 2025 A trial of a